Skip to main content
. 2022 Jun 1;100(6):445–449.

Table 1. Demographic and clinical characteristics, polygraphy findings and laboratory variables of the study population.

Variables

Mild OSAS group (n=63)

Moderate OSAS group (n=39)

Severe OSAS group (n=58)

p-value

Age (years)

50.92±11.45

53.3±13.28

53.18±7.97

0.420

Sex (Males/Females)

18/45

15/24

26/32

0.175

BMI (kg/m²)

30.11±5.27

32.02±6.18

32.53±5.75

0.094

CVD : n (%)

14 (20.96)

17 (25.8)

28 (45.16)

0.007

Hyperlipidemia : n (%)

11 (29.72%)

8 (18.91)

16 (43.24)

0.39

Diabetes mellitus : n (%)

13 (5.29)

8 (23.52)

12 (35.29)

0.99

Smoking : n (%)

10 (20)

10 (27.5)

17 (42.5)

0.197

AHI

8.64±.09

20.2±4.3

48.56±18.17

<0.001

Lowest saturation (%)

81.68±10.09

81.5±7.59

73.96±9.48

<0.001

Desaturation index

8.28±7.1

17.45±8.24

43.07±19.72

<0.001

Snoring rate (%)

13.76±10.87

23.36±12.52

30.27±16.63

<0.001

RDW (%)

13.8±1.13

14.33±1.3

14.97±1.33

<0.001

WBC (109/mm3)

6,65±1.55

6.58±2.25

7.25±1.71

0.12

Hb (g/dL)

13.2±0.98

1 3.10±1.02

13.38±1.13

0.45

Plt (103/mm3)

231.6±51.85

251.78±5.75

229.58±66.72

0.185

CRP (mg/L)

5.08±4,39

6.35±3.54

8.54±4.57

<0.001

AHI: Apnea Hypopnea Index; BMI: body mass index; CVD: cardiovascular disease; CRP: C-reactive protein; Hb: hemoglobin level; N: number ofpatients; OSAS: Obstructive sleep apnea syndrome; Plt: platelet count;RDW: red cell distribution width; WBC: white blood cells.